组蛋白去乙酰化酶泛抑制剂panobinostat在淋巴瘤中激活癌基因PIK3C2B的机制研究
81702991
2017
H1814.肿瘤化学药物治疗
王方
青年科学基金项目
助理研究员
四川大学
20万元
鉴定;机制;磷脂酰肌醇3-激酶Ⅱ类B型;组蛋白去乙酰化酶;调控
2018-01-01到2020-12-31
- 中英文摘要
- 结题摘要
- 结题报告
- 项目成果
- 项目参与人
查看更多信息请先登录或注册
查看更多信息请先登录或注册
查看更多信息请先登录或注册
| 序号 | 标题 | 类型 | 作者 |
|---|---|---|---|
| 1 | Discovery of Novel Dual Histone Deacetylase and Mammalian Target of Rapamycin Target Inhibitors as a Promising Strategy for Cancer Therapy | 期刊论文 | Chen Yong;Yuan Xue;Zhang Wanhua;Tang Minghai;Zheng Li;Wang Fang;Yan Wei;Yang Shengyong;Wei Yuquan;He Jun;Chen Lijuan |
| 2 | Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor of HDACs for the Treatment of BCR-ABL–Induced B-Cell Acute Lymphoblastic Leukemia | 期刊论文 | Linyu Yang;Qiang Qiu;Minghai Tang;Fang Wang;Yuyao Yi;Dongni Yi;Zhuang Yang;Zejiang Zhu;Shoujun Zheng;Jianhong Yang;Heying Pei;Li Zheng;Yong Chen;Liping Gou;Liya Luo;Xing Deng;Haoyu Ye;Yiguo Hu;Ting Niu;Lijuan Chen |
| 3 | Identification of Pyrrolo[2,3-d]pyrimidine-Based Derivatives as Potent and Orally Effective Fms-like Tyrosine Receptor Kinase 3 (FLT3) Inhibitors for Treating Acute Myelogenous Leukemia | 期刊论文 | Yuan Xue;Chen Yong;Zhang Wanhua;He Jun;Lei Lei;Tang Minghai;Liu Jiang;Li Muzhou;Dou Caixia;Yang Tao;Yang Linyu;Yang Shengyong;Wei Yuquan;Peng Aihua;Niu Ting;Xiang Mingli;Ye Haoyu;Chen Lijuan |
查看更多信息请先登录或注册
